Publications by authors named "Li-chi Han"

KRAS gene mutations are common in pancreatic ductal adenocarcinoma (PDAC), but targeting mutant KRAS is still challenging. Here, an endoribonuclease-prepared small interfering RNA (esiRNA) library was used to screen new kinases that play critical roles in PDAC driven by KRAS gene mutations, and serine/threonine kinase 31 (STK31) was identified and characterized as a potential therapeutic target for KRAS-mutant PDAC. Our results showed that STK31 was upregulated in KRAS-mutant PDAC patients with poor survival and highly expressed in PDAC cell lines with KRAS mutation.

View Article and Find Full Text PDF

Menopausal syndrome includes the symptoms that most women experience owing to hormone changes after menopause. Although hormone replacement therapy is a common treatment for menopausal syndrome, there are still many side effects and challenges hindering research. In this study, thioglycolic acid (TGA)-immobilized chitosan mucoadhesive gel was synthesized by a new method of low concentration of 1,4-butanediol diglycidyl ether (BDDE) would encapsulate di(2-ethylhexyl) phthalate (DEHP) as an alternative hormone replacement therapy for menopausal syndrome.

View Article and Find Full Text PDF

Several studies have focused on using cell carriers to solve the problem of mesenchymal stem cell expansion on regenerative medicine. However, the disadvantages of using prolonged enzymatic treatment and low cell harvest efficiency still trouble researchers. In this study, PNIPAAm-immobilized gelatin microspheres (abbreviated as GNMS) were synthesized using a simple power-driven flow-focusing microinjection system.

View Article and Find Full Text PDF

Tissue engineered cultured meat has been proposed as an emerging innovative process for meat production to overcome the severe consequences of livestock farming, climate change, and an increasing global population. However, currently, cultured meat lacks organized tissue structure, possesses insufficient fat content, and incurs high production costs, which are the major ongoing challenges. In this study, a developed scaffold was synthesized using gelatin and soymilk to create a friendly environment for myogenesis and adipogenesis in C2C12 and 3T3-L1 cells, respectively.

View Article and Find Full Text PDF

Long non-coding RNA HOX Transcript Antisense RNA (HOTAIR) is overexpressed in multiple cancers with diverse genetic profiles. Importantly, since HOTAIR heavily contributes to cancer progression by promoting tumor growth and metastasis, HOTAIR becomes a potential target for cancer therapy. However, the underlying mechanism leading to HOTAIR deregulation is largely unexplored.

View Article and Find Full Text PDF

Body sculpture is a common method to remove excessive fat. The diet and exercise are the first suggestion to keep body shape; however, those are difficult to keep adherence. Ultrasound has been developed for fat ablation; however, it could only serve as the side treatment along with liposuction.

View Article and Find Full Text PDF
Article Synopsis
  • Gemcitabine resistance is a major issue in pancreatic ductal adenocarcinoma (PDAC), and identifying biomarkers and therapeutic targets is crucial for improving patient outcomes.
  • A study used RNA interference screening to find genes affecting gemcitabine resistance and focused on the role of LLGL1, revealing that low levels of LLGL1 in tumors were linked to shorter survival times in patients.
  • Silencing LLGL1 increased OSMR expression, contributing to gemcitabine resistance; conversely, knocking down OSMR improved chemosensitivity, highlighting the significance of the LLGL1-OSMR pathway in PDAC treatment.
View Article and Find Full Text PDF

Background/aim: Drynaria fortunei (Gusuibu; GSB) is a popular traditional Chinese medicine used for bone repair. An increasing number of studies have reported that GSB induces osteogenic differentiation in bone marrow mesenchymal stem cells (BMSCs). These results provide insight into the application of GSB for bone tissue engineering techniques used to repair large bone defects.

View Article and Find Full Text PDF

HOXA transcript at the distal tip (HOTTIP), a long noncoding RNA, is upregulated in pancreatic ductal adenocarcinoma (PDAC), but the HOTTIP-mediated oncogenic pathway is not fully understood. We identified canonical HOTTIP-HOXA13 targets, CYP26B1, CLIC5, CHI3L1 and UCP2-responsible for cell growth and cell invasion. Genome-wide analysis revealed that 38% of HOTTIP-regulated genes contain H3K4me3 and HOTTIP enrichment at their promoters, without HOXA13 binding.

View Article and Find Full Text PDF
Article Synopsis
  • Long noncoding RNAs (lncRNAs) TCAM1P-004 and RP11-598D14.1 are often downregulated in hepatocellular carcinoma (HCC) and function as tumor suppressors.
  • Their repression is caused by the histone methyltransferase EZH2, which modifies their promoters and restricts their expression.
  • The loss of these lncRNAs disrupts critical protein interactions that normally regulate essential pathways, promoting cancer cell growth and HCC development, indicating EZH2 as a potential therapeutic target.
View Article and Find Full Text PDF

Berberine is a Chinese herbal medicine extracted from rhizoma coptidis that functions to improve insulin resistance, hyperlipidemia, hepatosteatosis and inflammation. Berberine can modify the activity of cell metabolism and signaling pathways by regulating expression of genes. However, the roles and effects of differential microRNA (miRNA) expression induced by berberine treatment are largely unexplored.

View Article and Find Full Text PDF

Assessing the neutralization capability of nonlethal but medically relevant toxins in venom has been a challenging task. Nowadays, neutralization efficacy is evaluated based simply on the survival rates of animals injected with antivenom together with a predefined dose of venom, which can determine potency against neurotoxicity but not validate the capability to neutralize cytotoxin-induced complications. In this study, a high correlation with in-vivo and in-vitro neutralization assays was established using the immunoreactive peptides identified from short-chain neurotoxin and cytotoxin A3.

View Article and Find Full Text PDF
Article Synopsis
  • Non-small cell lung cancer (NSCLC) is the leading cause of cancer deaths globally, and current therapies targeting certain pathways are insufficient for most patients, highlighting the need for new treatments.
  • The study investigated the effects of a medicinal fungus-derived extract, HS7, on NSCLC cells, revealing that it significantly inhibits key cancer-related signaling pathways (AKT-mTOR, ERK, and STAT3) and promotes cell death.
  • HS7 showed potential as an alternative treatment for NSCLC, especially for cases resistant to existing tyrosine kinase inhibitors (TKIs), by inducing important cell cycle regulators and suppressing cancer cell proliferation.
View Article and Find Full Text PDF

MicroRNA-34a (miR-34a) is frequently downregulated in pancreatic ductal adenocarcinoma (PDAC) cells, however, the silencing mechanism remains unclear. Enhancer of zeste homolog 2 (EZH2) is overexpressed in PDAC, and our previous miRNA profiling showed that inhibition of EZH2 in PDAC cells led to the re-expression of a group of tumor suppressor miRNAs including miR-34a. Here, we studied the effect of ectopic EZH2 expression to the silencing of miR-34a, and identified HOTAIR as an interacting partner to induce heterochromatin formation during miR-34a repression.

View Article and Find Full Text PDF
Article Synopsis
  • Small molecules that can restore the expression of specific microRNAs (miRNAs) downregulated in tumors show promise as new cancer treatments, particularly for hepatocellular carcinoma (HCC).
  • In a study using a reporter system for miR34a, researchers identified a compound called Rubone, which effectively upregulates miR34a in HCC cells with intact p53 but has no adverse effects on normal liver cells.
  • In preclinical tests on mice with HCC, Rubone significantly reduced tumor growth and was more effective than sorafenib, indicating its potential as a therapeutic agent that works by enhancing miR34a's tumor-suppressing role.
View Article and Find Full Text PDF

Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, and chronic hepatitis B virus (HBV) infection is the major risk factor of HCC. The virus encodes HBV X (HBx) protein that plays a critical role in the development of HCC. Studies have revealed numerous HBx-altered genes and signalling pathways that heavily contribute to tumourigenesis of non-tumour hepatocytes.

View Article and Find Full Text PDF

Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and is the third most common cause of cancer-related deaths. Currently available treatment options for HCC patients are scarce resulting in an urgent need to develop a novel effective cure. Polygonum capitatum is a medicinal herb which has been used to treat inflammatory diseases in Miao nationality of China.

View Article and Find Full Text PDF

Pervasive transcription occurs in the human genome to generate thousands of RNA transcripts, and accumulating evidence suggested that the RNA molecules, without protein coding ability, have important roles in diverse biological functions. Long non-coding RNA (lncRNA), with size larger than 200 nt, is a new class of the non-coding RNA that contributes to cancer development and progression. Roles for several lncRNAs in cancers have been characterized and strategies targeting them have inhibitory effects to malignant cells in vitro and in vivo.

View Article and Find Full Text PDF

Background & Aims: Enhancer of zeste homolog 2 (EZH2) is a histone methyltransferase that is overexpressed by pancreatic ductal adenocarcinoma (PDAC) cells and increases their aggressiveness. We identified microRNAs (miRs) that are regulated by EZH2 and studied their functions in PDAC cells.

Methods: We performed miR profile analysis of PDAC cells incubated with EZH2 inhibitor 3-deazaneplanocin A, and pancreatic ductal epithelial cells that overexpressed EZH2.

View Article and Find Full Text PDF

Background: Glioblastoma multiforme (GBM) is a form of highly malignant brain tumour. Temozolomide (TMZ) is the standard agent for GBM, but TMZ-resistance is common and accounts for many treatment failures. MicroRNA-21 (miR-21) is a non-coding RNA that plays critical roles in many biological processes in cancer, including chemoresistance.

View Article and Find Full Text PDF

Background: It is widely understood that tumor cells express tumor-associated antigens (TAAs), of which many are usually in low immunogenicity; for example, carcinoembryonic antigen (CEA) is specifically expressed on human colon cancer cells and is viewed as a low-immunogenic TAA. How to activate host immunity against specific TAAs and to suppress tumor growth therefore becomes important in cancer therapy development.

Results: To enhance the immune efficiency of CEA in mice that received, we fused a partial CEA gene with exogenous SARS-CoV fragments.

View Article and Find Full Text PDF
Article Synopsis
  • Aberrant Wnt/β-catenin signaling is crucial in colon cancer development, and HS7, an extract from Taiwanofungus camphoratus, shows promise in treating this cancer.
  • The study found that HS7 effectively inhibits the growth of human colon cancer cells (HT29, HCT116, SW480) by inducing apoptosis and suppressing Wnt/β-catenin signaling in a dose- and time-dependent manner.
  • Key mechanisms include increasing the Bax/Bcl-2 ratio, activating caspase-3, and inhibiting transcriptional activities related to important genes involved in cancer progression, suggesting HS7 may be beneficial in integrative cancer therapy.
View Article and Find Full Text PDF

Propofol anesthesia and sedation are known to downregulate the functions of many hematopoietic cells, such as macrophages and neutrophils, in vivo. However, the effects of propofol on secretion of the regulatory cytokine transforming growth factor β1 (TGF-β1) in vivo are unknown. In this study, the effects of propofol on TGF-β1 expression in human peripheral blood mononuclear cells, umbilical vein endothelial cells (HUVECs), lymphocytes (Jurkat) and monocytes (THP-1) were tested.

View Article and Find Full Text PDF